Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Tracking transcriptional activities with high-content epifluorescent imaging.

Hua J, Sima C, Cypert M, Gooden GC, Shack S, Alla L, Smith EA, Trent JM, Dougherty ER, Bittner ML.

J Biomed Opt. 2012 Apr;17(4):046008. doi: 10.1117/1.JBO.17.4.046008.

PMID:
22559686
2.

Gene expression profiling of tissues and cell lines: a dual-color microarray method.

Shack S.

Methods Mol Biol. 2011;700:125-43. doi: 10.1007/978-1-61737-954-3_9.

PMID:
21204031
3.

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer.

Balagurunathan Y, Morse DL, Hostetter G, Shanmugam V, Stafford P, Shack S, Pearson J, Trissal M, Demeure MJ, Von Hoff DD, Hruby VJ, Gillies RJ, Han H.

Mol Cancer Ther. 2008 Sep;7(9):3071-80. doi: 10.1158/1535-7163.MCT-08-0402. Epub 2008 Sep 2.

4.

Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity.

Shack S, Wang XT, Kokkonen GC, Gorospe M, Longo DL, Holbrook NJ.

Mol Cell Biol. 2003 Apr;23(7):2407-14.

5.

Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities.

Ikeyama S, Kokkonen G, Shack S, Wang XT, Holbrook NJ.

FASEB J. 2002 Jan;16(1):114-6. Epub 2001 Nov 14.

PMID:
11709495
6.

Activation of the cholesterol pathway and Ras maturation in response to stress.

Shack S, Gorospe M, Fawcett TW, Hudgins WR, Holbrook NJ.

Oncogene. 1999 Oct 28;18(44):6021-8.

7.

Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers.

Samid D, Hudgins WR, Shack S, Liu L, Prasanna P, Myers CE.

Adv Exp Med Biol. 1997;400A:501-5. Review.

PMID:
9547596
8.

Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate.

Gorospe M, Shack S, Guyton KZ, Samid D, Holbrook NJ.

Cell Growth Differ. 1996 Dec;7(12):1609-15.

9.

Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.

Shack S, Miller A, Liu L, Prasanna P, Thibault A, Samid D.

Clin Cancer Res. 1996 May;2(5):865-72.

10.
11.
12.
13.

Cinnamic acid: a natural product with potential use in cancer intervention.

Liu L, Hudgins WR, Shack S, Yin MQ, Samid D.

Int J Cancer. 1995 Jul 28;62(3):345-50.

PMID:
7628877
14.

Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells.

Sidell N, Wada R, Han G, Chang B, Shack S, Moore T, Samid D.

Int J Cancer. 1995 Feb 8;60(4):507-14.

PMID:
7829265
15.

Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.

Liu L, Shack S, Stetler-Stevenson WG, Hudgins WR, Samid D.

J Invest Dermatol. 1994 Sep;103(3):335-40.

16.

Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate.

Ram Z, Samid D, Walbridge S, Oshiro EM, Viola JJ, Tao-Cheng JH, Shack S, Thibault A, Myers CE, Oldfield EH.

Cancer Res. 1994 Jun 1;54(11):2923-7.

17.

Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.

Samid D, Ram Z, Hudgins WR, Shack S, Liu L, Walbridge S, Oldfield EH, Myers CE.

Cancer Res. 1994 Feb 15;54(4):891-5.

PMID:
8313377
19.

Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.

Samid D, Shack S, Sherman LT.

Cancer Res. 1992 Apr 1;52(7):1988-92.

20.

Supplemental Content

Support Center